Volume 86 Issue 15 | p. 33 | Concentrates
Issue Date: April 14, 2008

Harvard And Merck Form Research Pact

Department: Business

Harvard University's Office of Technology Development has signed a multiyear license and sponsored-research agreement with Merck & Co. focused on new osteoporosis therapies. Merck will fund research in the lab of immunology professor Laurie Glimcher. In return, it will get licenses to specific molecules that may result from the work. Glimcher studies the molecular pathways that lead to bone growth and looks for intervention points for enhancing bone formation or preventing osteoporosis in adults. Her lab has already identified several key mediators of bone growth that Merck hopes to use in the development of therapies.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment